Increased TERC gene copy number and cells in senescence in primary sclerosing cholangitis compared to colitis and control patients

Gene

Volumn 529, Issue 2, 2013, Pages 245-249

  Laish, Ido ^a   Katz, Hila ^a,b   Sulayev, Yael ^b   Liberman, Meytal ^a   Naftali, Timna ^a,c   Benjaminov, Fabiana ^a,c   Stein, Assaf ^a   Kitay Cohen, Yona ^a   Biron Shental, Tal ^a,c   Konikoff, Fred ^a,c   Amiel, Aliza ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

FISH; Primary sclerosing cholangitis; Senescence; Telomerase; TERC; Ulcerative colitis

Indexed keywords

ADULT; ARTICLE; CELL AGING; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE DURATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DOSAGE; GENE INSERTION; HETEROCHROMATIN; HUMAN; LYMPHOCYTE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

4,6 DIAMIDINO-2PHENYLINDOLE; C-REACTIVE PROTEIN; CD; COLORECTAL CARCINOMA; CRC; CROHN'S DISEASE; CRP; DAPI; DDR; DNA DAMAGE RESPONSE; FISH; FLUORESCENCE IN SITU HYBRIDIZATION; HARVEY-BRADSHAW INDEX; HBI; HTERT; HTR; HUMAN TELOMERASE REVERSE TRANSCRIPTASE; IBD; INFLAMMATORY BOWEL DISEASE; PBS; PHOSPHATE BUFFERED SALINE; PRIMARY SCLEROSING CHOLANGITIS; PSC; RNA TEMPLATE; SAHF; SENESCENCE; SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCI; TELOMERASE; TERC; TERC GENE, 3Q26; UC; ULCERATIVE COLITIS;

CASE-CONTROL STUDIES; CELL AGING; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; FEMALE; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; RNA; TELOMERASE;

EID: 84883792441     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.07.098     Document Type: Article

References (40)

1. Alvaro D. Serum and bile biomarkers for cholangiocarcinoma. Curr. Opin. Gastroenterol. 2009, 25:279-284.
2. Amiel A., Avivi L., Gaber E., Fejgin M.D. Asynchronous replication of allelic loci in Down syndrome. Eur. J. Hum. Genet. 1998, 6:359-364.
3. Amiel A., Fejgin M.D., Liberman M., Sharon Y., Kidron D., Biron-Shental T. Senescence in amniocytes and placentas from trisomy 21 pregnancies. J. Matern. Fetal Neonatal Med. 2013, 26:1086-1089.
4. Biron-Shental T., Kidron D., Sukenik-Halevy R., Goldberg-Bittman L., Sharony R., Fejgin M.D., Amiel A. TERC telomerase subunit gene copy number in placentas from pregnancies complicated with intrauterine growth restriction. Early Hum. Dev. 2011, 87:73-75.
5. Biron-Shental T., Kitay-Cohen Y., Tene T., Sharony R., Amiel A. Increased TERC gene copy number in amniocytes from fetuses with trisomy 18 or a sex chromosome aneuploidy. Gene 2012, 506:46-49.
6. Boberg K.M., Lind G.E. Primary sclerosing cholangitis and malignancy. Best Pract. Res. Clin. Gastroenterol. 2011, 25:753-764.
7. Bryce L.A., Morrison N., Hoare S.F., Muir S., Keith W.N. Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization. Neoplasia 2000, 2:197-201.
8. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522.
9. Cao Y., Bryan T.M., Reddel R.R. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci. 2008, 99:1092-1099.
10. Counter C.M., et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992, 11:1921-1929.
11. Epel E.S., et al. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17312-17315.
12. Foster S.S., De S., Johnson L.K., Petrini J.H., Stracker T.H. Cell cycle- and DNA repair pathway-specific effects of apoptosis on tumor suppression. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9953-9958.
13. Goldberg-Bittman L., Amiel A., Hadary R., Fejgin M.D., Quitt M., Kitay-Cohen Y. Telomere capture in hepatitis C infection. Cancer Genet. Cytogenet. 2009, 191:63-66.
14. Goldberg-Bittman L., Kitay-Cohen Y., Fejgin M.D., Hadary R., Quitt M., Amiel A. TERC telomerase subunit gene copy number in different disease stages of non-Hodgkin lymphoma and in hepatitis C. Cancer Invest. 2010, 28:181-185.
15. Hadi E., Sharony R., Goldberg-Bittman L., Biron-Shental T., Fejgin M.D., Amiel A. Telomere aggregates in trisomy 21 amniocytes. Cancer Genet. Cytogenet. 2009, 195:23-26.
16. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
17. Harvey R.F., Bradshaw M.J. Measuring Crohn's disease activity. Lancet 1980, 1:1134-1135.
18. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 1965, 37:614-636.
19. Herbig U., Sedivy J.M. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech. Ageing Dev. 2006, 127:16-24.
20. Hug N., Lingner J. Telomere length homeostasis. Chromosoma 2006, 115:413-425.
21. Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
22. Jenkins E.C., et al. Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome. Neurosci. Lett. 2008, 440:340-343.
23. Karlsen T.H., et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010, 138:1102-1111.
24. Kim N.W., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
25. Narita M., et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716.
26. Narita M., et al. A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation. Cell 2006, 126:503-514.
27. Plentz R.R., et al. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Hepatology 2004, 40:80-86.
28. Raynaud C.M., et al. DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer. Am. J. Clin. Oncol. 2010, 33:341-345.
29. Risques R.A., et al. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology 2008, 135:410-418.
30. Risques R.A., et al. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res. 2011, 71:1669-1679.
31. Salpea K.D., Nicaud V., Tiret L., Talmud P.J., Humphries S.E., EARS II group The association of telomere length with paternal history of premature myocardial infarction in the European Atherosclerosis Research Study II. J. Mol. Med. 2008, 86:815-824.
32. Sandborn W.J., et al. Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose escalation trial. Aliment. Pharmacol. Ther. 2004, 17:1355-1364.
33. Soder A.I., Hoare S.F., Muire S., Balmain A., Parkinson E.K., Keith W.N. Mapping of the gene for the mouse telomerase RNA component, TERC, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting. Genomics 1997, 41:293-294.
34. Stracker T.H., Petrini J.H. The MRE11 complex: starting from the ends. Nat. Rev. Mol. Cell Biol. 2011, 12:90-103.
35. Sukenik-Halevy R., Biron-Shental T., Sharony R., Fejgin M.D., Amiel A. Telomeres in trisomy 21 amniocytes. Cytogenet. Genome Res. 2011, 135:12-18.
36. Valdes A.M., et al. Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos. Int. 2007, 18:1203-1210.
37. Von Zglinicki T., Saretzki G., Döcke W., Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?. Exp. Cell Res. 1995, 220:186-193.
38. Wright W.E., Shay J.W. Historical claims and current interpretations of replicative aging. Nat. Biotechnol. 2002, 20:682-688.
39. Zhang R., Chen W., Adams P.D. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol. Cell Biol. 2007, 27:2343-2358.
40. Zipursky A., Brown E., Christensen H., Sutherland R., Doyle J. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Semin. Perinatol. 1997, 21:97-101.